Wealth Enhancement Advisory Services’s Ginkgo Bioworks DNA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	22,345 +10,438	+88%	+$87.3K	﹤0.01%	3572
2026 Q1	$82.2K	Buy	+11,907	New	+$99K	﹤0.01%	3355
2024 Q1	–	Sell	-286	Closed	-$19.3K	–	2503
2023 Q4	$19.3K	Sell	286 -37	-11%	-$2.27K	﹤0.01%	2257
2023 Q3	$23.4K	Buy	+323	New	+$25.8K	﹤0.01%	2191

Other funds holding DNA

BSWM

Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

CAL

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

HWA

HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

ATC

Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Wealth Enhancement Advisory Services's DNA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Ginkgo Bioworks (DNA) stake by 88% in Q2 2026, buying an estimated $87.3K and bringing the position to 22,345 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #3572.

Wealth Enhancement Advisory Services first reported a position in DNA in Q3 2023 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Wealth Enhancement Advisory Services held 22,345 shares of Ginkgo Bioworks worth $203K as of Q2 2026.
Wealth Enhancement Advisory Services bought 10,438 Ginkgo Bioworks shares in Q2 2026, an estimated $87.3K.
Ginkgo Bioworks made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3572 holding.
Wealth Enhancement Advisory Services first reported a position in Ginkgo Bioworks in Q3 2023 and has held it in 4 quarters since.
11 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.